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http://dx.doi.org/10.1016/j.fjs.2012.Summary Aims: Robot-assisted radical cystectomy (RARC) has been a popular mode of
therapy in the treatment of bladder carcinoma for several years, and its usage in bladder carci-
noma patients is on the rise. We evaluated the usefulness of this mode of therapy by studying
the clinical outcomes following RARC for the treatment of bladder carcinoma.
Methods: From 2006 to 2011, a total of eight patients in our hospital who underwent RARC for
bladder carcinomas were enrolled in this study. Clinical outcomes were measured by means of
preoperative status, operative strategy and initial outcomes.
Results: Follow-up ranged from 4 to 22 months (mean 10.9 months). The mean operative time
was 430.3 minutes, and the operative time decreased with the increasing experience of the
surgeon and assistants. The mean estimated blood loss was 762.5 mL. The surgical approach
was RARC and orthotopic ileal neobladder in five patients (62.5%), bilateral nephrectomy with
RARC in two patients (25%), and RARC with ileal conduit alone in one patient (12.5%). Histolog-
ical examination showed five instances of stage pT1 tumor, one pT2 tumor, and two instances
of original tumor with extravesical disease (pT3b). One patient had lymph node involvement.
Postoperative complications included urethral stricture in one case and vesicovaginal fistula in
another. The mean hospital stay was 10.8 days (range 7e26 days). None of the patients had
a positive surgical margin. There was no surgical mortality in this series.t of Urology, Chang Gung University, Chang Gung Memorial Hospital-Linko, 5 Fu-Shing Street,
.org.tw (P.-L. Chang).
ight ª 2012, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights reserved.
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Robotic radical cystectomy for bladder carcinoma 179Conclusion: RARC is a challenging but safe and minimally-invasive method of treating bladder
carcinoma.
Copyright ª 2012, Taiwan Surgical Association. Published by Elsevier Taiwan LLC. All rights
reserved.Table 1 Patient demographics.
Number of patients 8
Mean age in years (range) 58.1 (42e79)
Sex
Male 5
Female 3
Body mass index in kg/m2 (range) 26.3
(21.3e40.5)
American Society of Anesthesiologists score
1 5
2 3
Clinical stage
T1 5
T2 1
T3 2
T4 0
Diversion type
Neobladder 5
Ileal conduit 1
RARC with bilateral nephroureterectomy 2
Mean follow-up (months) 10.9
RARC Z robot-assisted radical cystectomy.1. Introduction
The American Cancer Society has estimated that nearly
71,000 Americans were diagnosed as having bladder cancer
in 2009.1e3 Radical cystectomy (RC) is the gold standard
surgical procedure for cases with muscle invasion and in
many high-risk superficial bladder cancer cases. Minimally-
invasive approaches to RC have been gaining popularity and
have the potential to address some of the drawbacks of
conventional open RC. Laparoscopic and robot-assisted
radical cystectomy (RARC) have been performed since
2005 in several institutions.4e6 RARC is an accepted option
where RC is indicated. This is a learning curve-associated
method that involves the acquisition of proficiency in
robotic surgery. The number of cases suggested before
a surgeon is considered proficient for RARC varies widely in
the related literature.7 RARC provides functional and
oncological results similar to those of its open counterpart,
with the advantage of being minimally invasive.7
In previous reports, minimally-invasive surgery for
bladder carcinoma, such as laparoscopic or robot-assisted
techniques for RC have been mentioned as acceptable
surgical techniques, and the perioperative results of RARC
have been deemed acceptable. The potential benefits of
RARC are that it is safe and quick, resulting in less blood
loss, there is less postoperative discomfort, and patients
have a shorter hospital stay than with open surgery, leading
to an earlier resumption of normal activities.7 The surgical
technique is still at an early period of evaluation, however,
and there are currently no randomized trials comparing
open RC to RARC or to other more conventional forms of
therapy. The purpose of the present study was to evaluate
our early experience with regard to RARC in bladder
carcinoma patients in order to improve understanding of
the feasibility of this procedure and to provide insight into
inherent selection bias. Clinical, perioperative, and path-
ological outcomes are reported.
2. Patients and methods
The da Vinci Surgical System was installed in our hospital in
September 2006. A total of eight cases of robotic RC were
performed for advanced bladder cancer by a single surgeon
at the Chang Gung Memorial Hospital-Linko between
September 2006 and November 2011. Table 1 shows the
clinical data collected prospectively.
2.1. Step 1: Patient position and port placement
The patients were placed in the Trendelenburg position with
their legs abducted. A Foley catheter was inserted into the
bladder and a pneumoperitoneumwas created with a Veressneedle. The transperitoneal approach was used, with the
placement of six ports (Fig. 1). A 12-mm port was placed on
the upper part of the umbilicus for the scope. Two 8-mm
ports for the instrument arms were placed approximately
8e10 cm from the camera port. Three additional ports
(usually two 12-mmports and one 5-mmport) were placed on
both sides of the abdomen for retraction and suction
purposes by the assistant as well as for the insertion of suture
materials using the technique described byManoharan et al.8
The robot was then moved into place.2.2. Step 2: Ureteral and posterior dissection
The procedure also followed the technique described by
Manoharan et al.8 The sigmoid colon was reflected and both
ureters dissected all the way to the bladder. Hem-o-lok
clips (Weck Closure Systems, Research Triangle Park, NC,
USA) were applied to the distal ureter. The ureteral margin
was sent for frozen section to rule out cancer invasion. In
men, the peritoneum over the rectovesical pouch was
incised, and the rectovesical space was dissected to the
apex of the prostate. In women, the Pouch of Douglas was
incised at the junction between the uterus and the poste-
rior vaginal wall. A hysterectomy and salpingo-
oophorectomy was performed in all of the women. We
modified this procedure and used the longitudinal incision
for extirpation of the bladder tumor.
Figure 2 Operative time in hours for each of the eight
patients.
8mm Robotic port
5mm Suction port
* Longitudinal incision
12mm camera and assistant port
Figure 1 Port placement.
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of the bladder
The peritoneum lateral to the medial umbilicus ligament
was divided, creating a space in which to dissect the lateral
bladder pedicles. The lateral pedicle was divided and was
attached to the prostateevesicular junction using LigaSure.
In men, the anterior dissection of the prostate urethral by
incised the endopelvic fascia and the apex of the dorsal
venous complex was suture-ligated with 2-0 Vicryl suture.
The apex of the prostate was dissected and divided using
scissors at the prostate apex of the urethra. In women, the
dorsal venous complex was suture-ligated with 2-0 Vicryl
suture, and the urethra dissected away from the apex of
the bladder. The specimen was removed in an Endo Catch.
2.4. Step 4: Pelvic lymph node dissection
One assistant and six ports were used in our robotic oper-
ations. Bilateral pelvic lymphadenectomy was performed
medially to the obturator nerve, laterally up to the geni-
tofemoral nerve, caudally up to the femoral canal, and
cranially to the bifurcation of the common iliac vessels. The
pelvic lymph nodes were routinely sent to the pathology
department to ascertain the exact pathological stage in our
cases. The pathological review was performed and the
report written according to the 1997 TNM staging system
standard.9
2.5. Step 5: Longitudinal incision
A longitudinal incision was made in the middle of the lower
abdomen and 2 cm above the symphysis pubis (Fig. 1). The
length of the incision wound was about 4e5 cm. The
specimen was removed through the incision.
2.6. Step 6: Reconstruction of the ileal neobladder
Extracorporeal urinary diversion was used in all patients
(ileal conduit in 1, ileal neobladder in 5). Simultaneous
bilateral nephroureterectomy was performed in two
patients for a nonfunctioning kidney secondary to uremia.
The bowel was resected, and intestinal continuity was re-
established using a stapled anastomosis. A standard
W-pouch ileal neobladder was constructed. 82.7. Step 7: Urethral-neobladder anastomosis and
ureterointestinal anastomosis
Intracorporeal urethraleneobladder anastomosis was per-
formed over an 18 F silicon Foley catheter. Refluxing
ureterointestinal anastomosis was performed using a 5-
0 polyglecaprone suture. In the ileal loop, extracorporeal
ureterointestinal anastomosis was performed in the same
way. Single J stents were placed in both ureters. The neo-
bladder was closed, and the stents were brought through
the neobladder to the anterior abdominal wall. At this
point, a Jackson-Pratt drain was put in place. The abdom-
inal wall closure was performed with a 3-0 absorbed suture.
All patients were followed-up regularly at our outpatient
department at 1e3-month intervals. The data collected
included clinical staging, body mass index, American
Society of Anesthesiologist score, and pathological grading.
Operative outcome measurements included operative time,
estimated blood loss and complications. Postoperative
outcome measurements included hospital stay and cathe-
terization time. Statistical analyses were performed using
Microsoft Office Excel (Microsoft Corp. Redmond, WA, USA).3. Results
The descriptive variables of the eight patients are shown in
Table 1. The study population consisted of five men and three
women,withameanageof58.1years (range42e79years).The
mean follow-up time was 10.9 months (range 4e22 months).
Themean operative timewas 430.3minutes, and the operative
time decreased with the increasing experience of the surgeon
and assistants. The mean estimated blood loss was 762.5 mL.
Fig. 2 shows the total da Vinci Surgical System operative time
in the eight patients. The mean blood loss is shown in Fig. 3.
No intraoperative hallow organ injury or positive surgical
marginwas noted. Table 2 summarizes the postoperative data.
The surgical pathological examination revealed stage
pT1in five patients. One patient had a pT2 tumor and two
patients had T3b tumors. In one case, the tumor was deter-
mined to be pathological lymph node positive-disease. The
Figure 3 Blood loss during robot-assisted laparoscopic
radical cystectomy.
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this study. Regarding the mode of urinary diversion, five
patients (62.5%) underwent an orthotopic urinary diversion,
one underwent ileal conduit, and the remaining two under-
wentbilateral nephrectomywith cystectomywithout urinary
diversion. Postoperative complications included urethral
stricture in one case and vesicovaginal fistula in another.
There was no surgical mortality in this series.4. Discussion
When RC is performed laparoscopically or robotically, it is
very challenging and the techniques duplicate the surgicalTable 2 Postoperative data from the eight cases.
Number of cases (%)
Histopathological stage (TNM)
T1N0M0 4 (50)
T1N1Mx 1 (12.5)
T2N0M0 1 (12.5)
T3bN0M0 2 (25)
Pathological grade
2 (high grade TCC) 5 (62.5)
3 (high grade TCC) 3 (37.5)
Node classification
Node-positive 1 (12.5)
Harvested node (number)
Median 3
Positive surgical margin 0
Postoperative complications 2 (25)
Urethral stricture 1 (12.5)
Vesicovaginal fistula 1 (12.5)
Mean urethral catheterization (days) 21
Mean blood loss in mL (range) 762.5 (100e1800)
Mean operative time in min (range) 430.3 (240e540)
Mean hospital stay in days (range) 10.8 (7e26)
Intraoperative blood transfusion
(no. of patients)
5 (62.5)
TCC Z transitional cell carcinoma.principles of open surgery.10,11 As such, RARC appears to be
an appropriate surgical option for carefully selected
patients.11e13 The robotic technique is still at an early
stage of evaluation, especially with regard to oncological
outcomes in our hospital. Performing RARC completely
intracorporeally is a lengthy procedure because it involves
the extirpation of the bladder and subsequent urinary
diversion. The initial attempts at intracorporeal neobladder
construction had a mean operating time of 8.5 hours.11,12
RARC has been accepted and been shown to be useful in
the treatment of advanced bladder cancers. The da Vinci
Surgical System provides three-dimensional visualization
and incorporates wristed instrumentation, which are
advantageous in intracorporeal suturing and beneficial in
visualization of the surgical plans for dissection. This
robotic procedure is thus much easier to carry out than
standard laparoscopic RC.14
We have performed eight procedures using RARC and
extracorporeal urinary diversion at our institution, and our
initial experience has been favorable as compared to our
past experience using open or laparoscopic RC. We have
found that it provides equally good exposure to the pelvic
lymph nodes and pelvic vessels when compared with RC
(including open and laparoscopic surgery). We observed no
significant difference in operative time or blood loss
between RARC and open surgery. Patients were able to
start an oral diet significantly earlier following RARC,
however, than after open surgery.
The present analysis had some limitations that are worth
noting. No imaging node-positive cases were chosen for the
RARCgroup. In somepatients selectionbiaswaspresent in the
real-time decisions regarding which patients would undergo
robotic versus open surgery. Further investigation of the
prognostic implications of robotic surgery in bladder carci-
nomaandmore advanced stagedisease through aprospective
study with a larger cohort of patients is needed.
We have found this method to be a safe, effective and
favorable procedure for the management of advanced
bladder cancer. Additional studies and a larger number of
cases are required, however, to further evaluate the
benefits of this approach.
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